Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Angelo’s Stergiou, CEO of Sellas Life Sciences, says that his company is already standing on a final leukemia vaccine, but thanks to artificial intelligence, another change-resistant cancer vaccine-am horizon could be.
“I think it will be a revolutionary decade in medicine and clinical research,” he said on Thursday about “Fox & friends. “
“Where AI comes into play with the results, we can either create a certain vaccine or a certain treatment, or we can say that this specific treatment works for the patient.”
AI is expected to revolutionize treatments for cancer in the next few years. (IStock)
How long will the technology take to develop? Stergiou predicts that the first of the specialized vaccines could come within the next three to four years.
“It is very important to understand that if you put garbage into this algorithm, you get trash out, so the medical community will require a lot of effort to adequately fit this data record, and it will be an ongoing evolutionary thing. “
You have an expert And “a future day”, Mark Beckman, who also came to “Fox & Friends” on Thursday, the AI revolution calls the “age of imagination”.
AI could predict whether cancer treatments will work, experts say: “Exciting time in medicine”
When he spoke to the hosts on the curvy couch, he noticed the new AI research system from Google, Amie, which is supposed to help find rare diseases and serve as a co-pilot for doctors.
“You have made some research and the ability to do so uncover these rare diseases And diseases are now at a very high level, so the doctors use this as an instrument to help them diagnose diagnosis. “
Click here to get the FOX News app